Postoperative TAC injections do not reduce the number of keloid recurrences. However, injection of keloid excision sites with IFN-alpha 2b offers a therapeutic advantage over keloid excision.
No takes yet. Share an insight, caveat, or question.
Berman et al. (1997) studied this question.